Enlivex Closes First $500K Tranche of $7.5M Offering; Remaining $7M Hinges on Nasdaq Listing
ENLV is trading near its 52-week low of $1 (15% above the low) on light trading volume (0.3× avg).
Summary
Enlivex closed the first $500,000 of a $7.5 million offering, but the remaining $7.0 million arrives in ten monthly tranches that stop if the stock loses its U.S. exchange listing — a live risk given the October 27 Nasdaq delisting notice.
Key Events · Financing and Capital Events · ENLV
-
First $500K Tranche Closes
Enlivex issued 380,232 ordinary shares at $1.315 plus 380,232 three-year warrants at a $1.578 strike on November 17, 2026, raising about $0.5 million gross before expenses.
-
Remaining $7M Tied to Nasdaq Listing
Investors committed to ten monthly closings of $0.7 million each from December 1, 2026 through September 1, 2027, but only while the shares remain listed on Nasdaq or another U.S. exchange; a delisting would cut off the remaining $7,000,000.
-
Delisting Notice Still Unresolved
The October 27, 2026 Nasdaq delisting notice remains the binding constraint on this financing — the bulk of the money is contingent on a listing the company has already been warned it may lose.
-
5% Royalty to Large Investors
Purchasers paying at least $850,000 receive 5% of upfront, milestone and royalty payments from future commercial deals and 5% of proceeds from any clinical asset sale, payable over five years.
Analysis · ENLV · Crypto Assets
Enlivex closed the first $500,000 of its $7.5 million registered direct offering on November 17, 2026, issuing 380,232 shares at $1.315 plus an equal number of three-year warrants struck at $1.578. The other $7.0 million is not in hand: investors committed to ten monthly $700,000 closings from December 1, 2026 through September 1, 2027, but those obligations are conditioned on the shares staying listed on Nasdaq or another U.S. exchange. Against the backdrop of the October 27, 2026 Nasdaq delisting notice, that condition is the whole story — a delisting would cut off the remaining $7,000,000, leaving the company with roughly $0.5 million gross from this raise. The agreement also grants investors paying at least $850,000 a 5% royalty on future licensing and asset-sale proceeds, a cost that does not show up in the dilution math. The company waived lock-ups from its November 24, 2025 private placement and agreed not to sell treasury RAIN before its December 2026 annual meeting.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENLV was trading at $1.15 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $1.00 to $434.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.